Re: Why have we not heard more about CURATE-AI?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Why have we not heard more about CURATE-AI?

in response to

Why have we not heard more about CURATE-AI?

narmac

posted on Mar 25, 2021 11:12AM

narmac, I recall Don making a statement something to the effect that if they wanted to continue using the CURATE system that Zenith would have to pay for it's use.

Obviously someone did not think it had enough value to pay for it.

Toinv

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply